Inside AstraZeneca’s abandoned UK vaccine plant deal as Labour and Tories face questions over £450m collapse
AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate ...
Inside AstraZeneca’s abandoned UK vaccine plant as Labour and Tories face questions over £450m collapse
AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate ...
Why Britain failed to close £450m AstraZeneca deal
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Investing1d
AIM ImmunoTech advances Ampligen for avian influenza vaccine
Investing.com -- AIM ImmunoTech (NYSE: AIM) Inc. (NYSE American: AIM) has announced its intention to develop Ampligen as a vaccine adjuvant for avian influenza. This move is part of AIM's antiviral ...
Shropshire Star1d
'Vaccines: The UK could lead the world' - Your Letters: February 7
AstraZeneca has cancelled plans for a £450m vaccine manufacturing plant in Liverpool, blaming a cut in funding from ...
The inside story of Britain’s failure to clinch £450mn AstraZeneca deal
How an agreement set up by the Tories and lauded by Labour fell victim to cost-cutting and UK curbs on drugs expenditure ...
Post the pandemic, how’s your Covid?
I pine for the good old days of man flu, where the slightest symptom, a cough, a sniffle or a general sense of malaise, could ...
AstraZeneca Could Pay $4.5 Million In China Scandal. Here's Why Shares Jumped.
AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.
Pharmaceutical Technology2d
AstraZeneca’s shares rise as it addresses China investigation
In addition to the UK investment controversy, AstraZeneca is also dealing with legal challenges in China. The company ...
Peer demands answers on AstraZeneca deal collapse
A Liberal Democrat peer has accused the government of favouring the south-east of England over Merseyside after AstraZeneca ...
AZN Q4 Earnings Lag, Sales Beat, Stock Up on China Probe Update
AstraZeneca reports mixed results in the fourth quarter. It gains in pre-market after assuring investors that the business ...
AstraZeneca 'very disappointed' after scrapping £450m vaccine plant in Liverpool
Pascal Soriot, chief executive of AstraZeneca, denied any rift with the Government over the decision, which it revealed ...